Stephen C. Glover
Chief Executive Officer, President, and Chairman
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | ZyVersa Therapeutics, Inc. (ZVSA) | Co-Founder, Chief Executive Officer President and Chairman | $550,000 | $993,217 |
| 2022 | ZyVersa Therapeutics, Inc. (ZVSA) | Co-Founder, Chief Executive Officer President and Chairman | $450,500 | $1,478,448 |
Executive changes
Earnings-call appearances
No earnings-call appearances recorded yet.